{"id":"https://openalex.org/W4391032001","doi":"https://doi.org/10.1080/07391102.2024.2305316","title":"Insightful t-SNE guided exploration spotlighting Palbociclib and Ribociclib analogues as novel WEE1 kinase inhibitory candidates","display_name":"Insightful t-SNE guided exploration spotlighting Palbociclib and Ribociclib analogues as novel WEE1 kinase inhibitory candidates","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-18","ids":{"openalex":"https://openalex.org/W4391032001","doi":"https://doi.org/10.1080/07391102.2024.2305316","pmid":"https://pubmed.ncbi.nlm.nih.gov/38239070"},"language":"en","primary_location":{"id":"doi:10.1080/07391102.2024.2305316","doi":"https://doi.org/10.1080/07391102.2024.2305316","is_oa":false,"landing_page_url":"https://doi.org/10.1080/07391102.2024.2305316","pdf_url":null,"source":{"id":"https://openalex.org/S178711970","display_name":"Journal of Biomolecular Structure and Dynamics","issn_l":"0739-1102","issn":["0739-1102","1538-0254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biomolecular Structure and Dynamics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4391032001"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093747917","display_name":"Rajesh Muthuraj","orcid":"https://orcid.org/0000-0002-8796-7307","observed_orcids":["https://orcid.org/0000-0002-8796-7307"]},"institutions":[{"id":"https://openalex.org/I20107917","display_name":"Sri Ramachandra Institute of Higher Education and Research","ror":"https://ror.org/0108gdg43","country_code":"IN","type":"education","lineage":["https://openalex.org/I20107917"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajesh Muthuraj","raw_affiliation_strings":["Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)","Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India"],"raw_orcid":"https://orcid.org/0000-0002-8796-7307","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)","institution_ids":["https://openalex.org/I20107917"]},{"raw_affiliation_string":"Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India","institution_ids":["https://openalex.org/I20107917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002275811","display_name":"Dhanushya Gopal","orcid":"https://orcid.org/0009-0003-1237-7323","observed_orcids":["https://orcid.org/0009-0003-1237-7323"]},"institutions":[{"id":"https://openalex.org/I20107917","display_name":"Sri Ramachandra Institute of Higher Education and Research","ror":"https://ror.org/0108gdg43","country_code":"IN","type":"education","lineage":["https://openalex.org/I20107917"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dhanushya Gopal","raw_affiliation_strings":["Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)","Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India"],"raw_orcid":"https://orcid.org/0009-0003-1237-7323","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)","institution_ids":["https://openalex.org/I20107917"]},{"raw_affiliation_string":"Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India","institution_ids":["https://openalex.org/I20107917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113099987","display_name":"Iqrar Ahmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iqrar Ahmed","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy","Division of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research","Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy, Dhule, India","Division of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India"],"raw_orcid":"https://orcid.org/0000-0002-7697-9572","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy","institution_ids":[]},{"raw_affiliation_string":"Division of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy, Dhule, India","institution_ids":[]},{"raw_affiliation_string":"Division of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010743456","display_name":"Jaikanth Chandrasekaran","orcid":"https://orcid.org/0000-0002-5088-9683","observed_orcids":["https://orcid.org/0000-0002-5088-9683"]},"institutions":[{"id":"https://openalex.org/I20107917","display_name":"Sri Ramachandra Institute of Higher Education and Research","ror":"https://ror.org/0108gdg43","country_code":"IN","type":"education","lineage":["https://openalex.org/I20107917"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Jaikanth Chandrasekaran","raw_affiliation_strings":["Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)","Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India"],"raw_orcid":"https://orcid.org/0000-0002-5088-9683","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University)","institution_ids":["https://openalex.org/I20107917"]},{"raw_affiliation_string":"Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India","institution_ids":["https://openalex.org/I20107917"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5010743456"],"corresponding_institution_ids":["https://openalex.org/I20107917"],"apc_list":null,"apc_paid":null,"fwci":2.0621,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.8805984,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"43","issue":"9","first_page":"4716","last_page":"4728"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wee1-kinase-inhibitor","display_name":"Wee1 kinase inhibitor","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ecfp4-fingerprints","display_name":"ECFP4 fingerprints","score":0.8999999761581421},{"id":"https://openalex.org/keywords/virtual-drug-discovery","display_name":"virtual drug discovery","score":0.45100000500679016},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.609000027179718},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/protein-ligand-interactions","display_name":"protein-ligand interactions","score":0.8870000243186951},{"id":"https://openalex.org/keywords/lipinski-s-rule-of-five","display_name":"Lipinski's rule of five","score":0.7009999752044678},{"id":"https://openalex.org/keywords/synthetic-accessibility","display_name":"synthetic accessibility","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.5649999976158142}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9638407230377197},{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.7921290397644043},{"id":"https://openalex.org/C41847442","wikidata":"https://www.wikidata.org/wiki/Q916723","display_name":"Lipinski's rule of five","level":4,"score":0.6062904000282288},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5254610776901245},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.44197195768356323},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4318106770515442},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.40967345237731934},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3973008990287781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35172542929649353},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33075401186943054},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.31632328033447266},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3050999343395233},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20584988594055176},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.1770082712173462},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.15380355715751648},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.13546216487884521},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1146010160446167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09362488985061646},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/07391102.2024.2305316","doi":"https://doi.org/10.1080/07391102.2024.2305316","is_oa":false,"landing_page_url":"https://doi.org/10.1080/07391102.2024.2305316","pdf_url":null,"source":{"id":"https://openalex.org/S178711970","display_name":"Journal of Biomolecular Structure and Dynamics","issn_l":"0739-1102","issn":["0739-1102","1538-0254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biomolecular Structure and Dynamics","raw_type":"journal-article"},{"id":"pmid:38239070","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38239070","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biomolecular structure & dynamics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.7246000170707703,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1752089945","https://openalex.org/W1978733464","https://openalex.org/W1983478747","https://openalex.org/W1992156271","https://openalex.org/W2009423060","https://openalex.org/W2028495676","https://openalex.org/W2061843861","https://openalex.org/W2135732933","https://openalex.org/W2138778824","https://openalex.org/W2140990686","https://openalex.org/W2142602210","https://openalex.org/W2151697120","https://openalex.org/W2160592148","https://openalex.org/W2187089797","https://openalex.org/W2419225477","https://openalex.org/W2470708296","https://openalex.org/W2744376322","https://openalex.org/W2886197400","https://openalex.org/W2899450762","https://openalex.org/W2983144541","https://openalex.org/W2997591727","https://openalex.org/W3002934983","https://openalex.org/W3035950992","https://openalex.org/W3087121815","https://openalex.org/W3094017465","https://openalex.org/W3115894562","https://openalex.org/W3126415325","https://openalex.org/W3131285796","https://openalex.org/W3149078497","https://openalex.org/W3206616643","https://openalex.org/W4367671368","https://openalex.org/W4379233325","https://openalex.org/W4386188235"],"related_works":["https://openalex.org/W6902484101","https://openalex.org/W7117244469","https://openalex.org/W6902350329","https://openalex.org/W7147215798","https://openalex.org/W2885005881","https://openalex.org/W7203476486","https://openalex.org/W4389442961","https://openalex.org/W2891302428","https://openalex.org/W7092542921"],"abstract_inverted_index":{"In":[0],"the":[1,33,42,57,72,113,129],"era":[2],"of":[3,91,106,131],"targeted":[4,177],"therapeutics,":[5],"protein":[6],"kinases":[7],"like":[8],"WEE1":[9,116,157],"have":[10],"become":[11],"pivotal":[12],"drug":[13,178],"targets,":[14],"especially":[15],"for":[16,68,78,100,136,156,172],"cancer":[17,181],"therapy.":[18],"Utilizing":[19],"a":[20,138,169],"multi-faceted":[21],"approach,":[22],"our":[23,163],"study":[24,152],"adds":[25],"fresh":[26],"insights":[27],"to":[28,40,60,88],"this":[29],"endeavour.":[30],"We":[31],"employed":[32],"t-SNE":[34,54],"algorithm,":[35],"combined":[36],"with":[37],"ECFP4":[38],"fingerprints,":[39],"analyse":[41],"molecular":[43],"similarity":[44],"between":[45],"FDA-approved":[46,66,81],"drugs":[47,67],"and":[48,63,93,108,122,176],"known":[49,61],"clinical":[50],"trial":[51],"inhibitors.":[52],"Our":[53,151],"analysis":[55],"identified":[56],"closest":[58],"clusters":[59],"inhibitors":[62],"selected":[64],"11":[65,80],"further":[69],"study.":[70],"Using":[71],"DrugSpaceX":[73],"platform,":[74],"we":[75,167],"generated":[76],"analogues":[77,84,99],"these":[79,132],"drugs.":[82],"These":[83],"were":[85],"refined":[86],"according":[87],"Lipinski's":[89],"Rule":[90],"Five":[92],"Synthetic":[94],"Accessibility":[95],"scores,":[96],"yielding":[97],"68,640":[98],"additional":[101],"scrutiny.":[102],"Among":[103],"these,":[104],"derivatives":[105],"Palbociclib":[107,140],"Ribociclib":[109],"stood":[110],"out":[111],"as":[112],"most":[114,145],"promising":[115],"inhibitors,":[117],"based":[118],"on":[119],"docking":[120],"scores":[121],"interaction":[123],"patterns.":[124],"Molecular":[125],"dynamics":[126],"simulations":[127],"validated":[128],"stability":[130],"protein-ligand":[133],"interactions,":[134],"particularly":[135],"DE50607359,":[137],"top-ranked":[139],"analogue,":[141],"which":[142],"also":[143],"met":[144],"pharmacokinetic":[146],"parameters":[147],"within":[148],"acceptable":[149],"limits.":[150],"uncovers":[153],"new":[154],"candidates":[155],"inhibition":[158],"not":[159],"previously":[160],"reported.":[161],"With":[162],"multi-layered":[164],"computational":[165],"strategy,":[166],"provide":[168],"solid":[170],"foundation":[171],"future":[173],"experimental":[174],"validation":[175],"development":[179],"in":[180],"therapeutics.":[182]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4391032001","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2024-01-20T00:00:00"}
